(Q36511608)

14 August 2017

1 reference

title

The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome (English)

1 reference

14 August 2017

D A Glaser

1

1 reference

14 August 2017

publication date

1 April 2006

1 reference

14 August 2017

published in

Neurotoxicity Research

1 reference

14 August 2017

volume

9

1 reference

14 August 2017

issue

2-3

1 reference

14 August 2017

page(s)

173-177

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03033936

14 August 2017

exact match

0 references

cites work

Botulinum toxin A in the treatment of patients with Frey syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03033936

Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033936

Recognition, diagnosis, and treatment of primary focal hyperhidrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033936

The use of botulinum toxin type A in the treatment of Frey and crocodile tears syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033936

Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033936

Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033936

Biology of sweat glands and their disorders. I. Normal sweat gland function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033936

US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033936

Magnetic resonance imaging and computed tomographic findings after temporal lobe injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03033936

Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis

21 January 2018

1 reference

12 December 2020

BOTOX delivery by iontophoresis

1 reference

12 December 2020

Successful treatment of axillary hyperhidrosis with very low doses of botulinum toxin B: a pilot study

1 reference

12 December 2020

Botulinum toxin type A for Frey's syndrome: a preliminary prospective study

1 reference

12 December 2020

Botulinum toxin type B for treatment of axillar hyperhidrosis

1 reference

12 December 2020

Botulinum A toxin improves life quality in severe primary focal hyperhidrosis

1 reference

12 December 2020

Treatment of Frey syndrome with botulinum toxin type F

1 reference

12 December 2020

Treatment of gustatory sweating with botulinum toxin

1 reference

12 December 2020

Up-to-date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey's syndrome)

1 reference

12 December 2020

Botulinum toxin--a possible new treatment for axillary hyperhidrosis

1 reference

12 December 2020

Frey's syndrome: treatment with botulinum toxin

1 reference

12 December 2020

Treatment of plantar hyperhidrosis with botulinum toxin type A

1 reference

12 December 2020

Increased Botulinum Toxin Type A Dosage Is More Effective in Patients With Frey???s Syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03033936

1 reference

14 August 2017

1 reference